Drug Type Fusion protein |
Synonyms |
Target |
Mechanism CD64 agonists(Immunoglobulin gamma Fc receptor I agonists) |
Therapeutic Areas |
Active Indication- |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 1 | ES | 17 Jul 2017 | |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 1 | GB | 17 Jul 2017 | |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 1 | BE | 17 Jul 2017 | |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 1 | NZ | 17 Jul 2017 | |
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 1 | US | 17 Jul 2017 | |
Purpura, Thrombocytopenic, Idiopathic | Phase 1 | NZ | 17 Jul 2017 | |
Purpura, Thrombocytopenic, Idiopathic | Phase 1 | US | 17 Jul 2017 | |
Purpura, Thrombocytopenic, Idiopathic | Phase 1 | ES | 17 Jul 2017 | |
Purpura, Thrombocytopenic, Idiopathic | Phase 1 | GB | 17 Jul 2017 | |
Purpura, Thrombocytopenic, Idiopathic | Phase 1 | BE | 17 Jul 2017 |